FIDUCIARY DISCRETION. 12.1 TransMedics’ Board approved professional advisors shall have full discretion to invest TransMedics Inc.’s portfolio subject to strict adherence to these guidelines.
12.2 TransMedics’ Board approved professional advisors, must comply with its appropriate rules and regulations as set forth by it’s governing bodies (i.e., the SEC). None. None.
1. TransMedics B. V., a Dutch limited liability company - 100% wholly owned by Borrower
2. TransMedics GmbH, a German limited liability company -100% wholly owned by TransMedics B.V.
3. TransMedics Pty Ltd, an Australian limited liability company - 100% wholly owned by Borrower
(1) TransMedics B.V.’s only employee in France is employed under the general conditions of the national collective bargaining agreement of the Manufacturing and Trade of Pharmaceutical, Para Pharmaceutical and veterinary products IDCC reference 1555 (the “Collective Bargaining Agreement”). The employee shall pertain to the level 10 of the Collective Bargaining Agreement.
(2) TransMedics B.V.’s only employee in Italy is subject to the national collective bargaining agreement for commercial executives (“CCNL Dirigenti Cemmercio”). 6,046,046 03-Apr-1998 COMPOSITIONS, METHODS AND DEVICES FOR MAINTAINING AN ORGAN September 23, 2017 6,100,082 23-Sep-1997 PERFUSION APPARATUS AND METHOD INCLUDING CHEMICAL COMPOSITIONS FOR MAINTAINING AN ORGAN May 20, 2019 6,953,655 23-Mar-2000 COMPOSITIONS, METHODS AND DEVICES FOR MAINTAINING AN ORGAN September 23, 2017 7,572,622 14-Aug-2003 HEART PRESERVATION CHAMBER January 29, 2026 7,651,835 07-0ct-2005 SYSTEMS AND METHODS FOR EX-VIVO ORGAN CARE March 13, 2027 8,304,181 25-Apr-2007 METHOD FOR EX-VIVO ORGAN CARE AND FOR USING LACTATE AS AN INDICATION OF DONOR ORGAN STATUS March 6, 2028 8,409,846 17-Feb-2005 COMPOSITIONS, METHODS AND DEVICES FOR MAINTAINING AN ORGAN September 23, 2017 8,420,380 08-Apr-2008 SYSTEMS AND METHODS FOR EX VIVO LUNG CARE October 28, 2029 8,465,970 07-0ct-2005 SYSTEMS AND METHODS FOR EX-VIVO ORGAN CARE February 12, 2028 8,535,934 19-Apr-2007 SYSTEMS AND METHODS FOR EX VIVO ORGAN CARE October 28, 2029 8,585,380 07-0ct-2005 SYSTEMS AND METHODS FOR EX-VIVO ORGAN CARE February 12, 2028 8,822,203 28-Sep-2010 SYSTEMS AND METHODS FOR EX VIVO ORGAN CARE November 20, 2028 9,055,740 07-0ct-2005 SYSTEMS AND METHODS FOR EX-VIVO ORGAN CARE June 15, 2028 9,078,428 07-0ct-2005 SYSTEMS, METHODS, COMPOSITIONS AND SOLUTIONS FOR PERFUSING AN ORGAN August 23, 2027 9,215,867 07-0ct-2005 SYSTEMS AND METHODS FOR...
FIDUCIARY DISCRETION. 12.1 The Chief Financial Officer or other individual appointed by the Board and his/her authorized employees are responsible for securing and managing investments and cash for operations.
12.2 These individuals have full discretion to invest any excess capital subject to strict adherence to these guidelines.
12.3 These guidelines are to be reviewed periodically with the Chief Financial Officer or Chief Executive Officer and revisions made consistent with objectives set forth herein. [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] by its duly authorised representative: Signature: /s/ Xxxx X. Xxxxxxxx Name: Xxxx X. Xxxxxxxx Title: SVP & General Counsel Date: 21 December 2011 Signed for and on behalf of Signed for and on behalf of THE WELLCOME TRUST LIMITED as THE WELLCOME TRUST LIMITED as trustee of the Wellcome Trust trustee of the Wellcome Trust by its duly authorised representative: by its duly authorised representative: Signature: /s/ Xx. Xxxxxxx Xxxxxxxx Signature: /s/ Xx. X.X. Xxxxxx
X. X. Xxxxxx
FIDUCIARY DISCRETION. The Chief Financial Officer or other individual appointed by the Board and his/her authorized employees are responsible for securing and managing investments and cash for operations. These individuals have full discretion to invest any excess capital subject to strict adherence to these guidelines. These guidelines and the performance of the investments are to be reviewed periodically with the Board of Directors and only then can guideline revisions be made.
FIDUCIARY DISCRETION. The manager has full discretion to invest capital subject to strict adherence to these guidelines. These guidelines are to be reviewed periodically by the Treasurer and revisions made consistent with objectives set forth herein. APPROVED BY: DATE: 11/17/97 ------------------------------------------------------ Xxxxxx X. Xxxxxxxxxxx, Treasurer -90- VERTEX PHARMACEUTICALS INC. INVESTMENT POLICY GUIDELINES FOR: CAPITAL ADVISORS
FIDUCIARY DISCRETION. 12.1 The Controller, or the Chief Executive Officer, or other individual appointed by the Board and his/her authorized employees are responsible for securing and managing investments and cash for operations. The Company fully indemnifies such individual(s) from any loss or harm arising from activities related to trading of the Company’s investment portfolio, provided all trades are made in accordance with this Policy.
12.2 These individuals have full discretion to invest any excess capital subject to strict adherence to these guidelines.
12.3 These guidelines are to be reviewed periodically with the Controller or Chief Executive Officer and revisions made consistent with objectives set forth herein.
FIDUCIARY DISCRETION. The Treasurer and his/her authorized employees are responsible for securing and managing investments and cash for operations. These individuals have full discretion to invest any excess capital subject to strict adherence to these guidelines. These guidelines are to be reviewed periodically with the Chief Business Officer and revisions made consistent with objectives set forth herein. EXHIBIT A TO CREDIT AGREEMENT TERM NOTE $20,000,000.00 Boston, Massachusetts December 21, 1999
FIDUCIARY DISCRETION. The Chief Financial Officer or other individual appointed by the Board and his/her authorized employees are responsible for securing and managing investments and cash for operations. These individuals have full discretion to invest any excess capital subject to strict adherence to these guidelines. These guidelines and the performance of the investments are to be reviewed periodically with the Board of Directors and only then can guideline revisions be made. By: Title: I, the Secretary or Assistant Secretary of Xenogen Corporation (“Borrower”), CERTIFY that Borrower is a corporation existing under the laws of the State of Delaware. I certify that at a meeting of Borrower’s Directors (or by other authorized corporate action) duly held the following resolutions were adopted. It is resolved that any one of the following officers of Borrower, whose name, title and signature is below: may act for Borrower and: Borrow Money. Borrow money from Silicon Valley Bank (“Bank”). Execute Loan Documents. Execute any loan documents Bank requires.
FIDUCIARY DISCRETION. 12.1 The Chief Financial Officer or Chief Executive Officer are responsible for securing and managing investments and cash for operations.
FIDUCIARY DISCRETION. 12.1 Capital Advisors Group, Inc. shall have full discretion to invest Amyris Biotechnologies’ portfolio subject to strict adherence to these guidelines.
12.2 Capital Advisers Group, Inc. shall act with the highest level of care, prudence, and diligence in carrying out the investment objectives set forth herein.
FIDUCIARY DISCRETION. The Chief Financial Officer or other individual appointed by the Board and his/her authorized employees are responsible for securing and managing investments and cash for operations. These individuals have full discretion to invest any excess capital subject to strict adherence to these guidelines. These guidelines are to be reviewed periodically with the Chief Financial Officer or Chief Executive Officer and revisions made consistent with objectives set forth herein. Date ______________ BY ___________________________________ Title BY ___________________________________ Title BY ___________________________________ Title
